in an A strain mouse and has been carried in our laboratory in ABC-ALB mice. Antigens from tumors and normal mouse organs were prepared by washing small pieces of the tissue (only healthy and non-necrotic tumor tissue was used) in two or three changes of distilled water after adding formalin to make a 0.5 per cent solution. Even though sterile precautions were always taken, chance contamination ruined many antigens until this technic was adopted. The aqueous suspension was tubed, incubated at 370 C. for from-4 to 7 hours, and placed at ice-box temperature over night; it was then centrifuged (2000 r.p.m. for 20 to 30 min.) and the supernatant was tubed and stored in the ice-box after sufficient concentrated NaCl had been added to bring it back to normglcy. The concentration of tumor in such an extract
Studies of the histology and growth characteristics of regressing transplantable tumor 15091a in mice suggested that regression followed the acquisition by the host of a specific immunological resistance against the graft.' To test this hypothesis serologically, two methods of approach have been employed. First, antibodies against tumor 15091a were sought in (a) mice in which the tumor had regressed, and (b) mice in which repeated transplants failed to grow. A subsidiary study was carried out with Sarcoma 37 in an attempt to confirm Hoyle4 by demonstrating the presence of antibodies against the sarcoma in mice carrying this tumor. Second, the antigenic nature of tumor 15091a was studied by (a) testing for antigenic differences or similarities between the tumor and organs from normal mice, and (b) testing for antigenic differences or similarities between tumor 15091a and other malignant mouse tumors, e.g., spontaneous mammary carcinomas and methylcholanthrene-induced sarcomas; and by (c) fractionating the extract of tumor 15091a to determine the characteristics of the antigenically active material.
Methods
Tumor 15091a,2 a transplantable mammary carcinoma, arose originally in an A strain mouse and has been carried in our laboratory in ABC-ALB mice. Antigens from tumors and normal mouse organs were prepared by washing small pieces of the tissue (only healthy and non-necrotic tumor tissue was used) in two or three changes of distilled water after adding formalin to make a 0.5 per cent solution. Even though sterile precautions were always taken, chance contamination ruined many antigens until this technic was adopted. The aqueous suspension was tubed, incubated at 370 C. for from-4 to 7 hours, and placed at ice-box temperature over night; it was then centrifuged (2000 r.p.m. for 20 to 30 min.) and the supernatant was tubed and stored in the ice-box after sufficient concentrated NaCl had been added to bring it back to normglcy. Results I. (a) Complement-fixation tests failed to demonstrate antibodies against tumor 15091a in dba or C Bagg Albino mice in which the tumor was regressing or had regressed. When the pooled, inactivated sera of two dba mice in which the tumor was regressing was tested in dilutions as low as 1: 4 there was no complement fixation. Nor were 1 5091 a antibodies found in inactivated pooled sera (lowest dilution tested, 1:2) of two dba mice in which the tumor was taking or in two normal dba mice. Sera of two C Bagg Albino mice in which transplants of 15091a had regressed 14 and 20 days before, respectively, were tested individually (a third was tried and found to be anticomplementary); one gave no reaction in dilutions as low *The amounts and temperatures used were: antigen 0.1 cc., serum to be tested 0.05 cc., complement (2 units) 0.1 cc., NaCl 0.1 cc.; primary incubation I hr. at 370 C.; hemolytic system amboceptor (2 units) 0.1 cc.; 2%o packed sheep cells 0.1 cc.; secondary incubation of 20 to 30 min. The tubes were then centrifuged and read.
as 1: 5 while the other gave complete fixation at 1: 5 and a trace at 1: 10. This is not considered to be of significance, since the serum of a normal C Bagg Albino mouse had given fixation at a dilution of 1: 4.
(b) Similarly, sera from two A.BC-ALB mice which had been completely resistant to 2 and 3 inoculations of tumor 15091a did not reveal the presence of specific protecting antibodies. The last transplant had been given about 1 month before bleeding. Pooled sera from these two mice and from 2 normal ABC-ALB mice were both negative when tested in dilutions as low as 1: 4.
Hoyle had demonstrated antibodies against Sarcoma 37 (designated S-37 below) in mice that were carrying this tumor.4 As a corollary to the above studies we attempted to confirm this finding. Serum from 1 dba mouse bearing a large S-37 tumor reacted with S-37 antigen at a dilution of 1: 8, but a normal dba did the same. The sera of two other S-3 7-bearing d;ba mice were set up individually against S-3 7 antigen but no reaction was found ( 1: 4 being the lowest dilution). S-37 is a tumor which becomes necrotic and secondarily infected very early; it is possible that antigen prepared even from healthy portions of the tumor included bacterial proteins which subsequently reacted non-specifically with the mouse sera.
II. Studies were undertaken to compare the antigenic properties of tumor 15091a with those of normal mouse organs and of other malignant mouse tumors, both spontaneous and induced. This was done by immunizing rabbits against 1 5091a and comparing the reactions of the antiserum when tested against antigens from these other sources with those obtained with the homologous antigen.
Eight rabbits developed definite titers against 15091a antigen; 3 were immunized by intravenous injections of the tumor antigen alone, one by intraperitoneal injections of fresh tumor and staphylococcus toxin, and 4 by intravenous tumor antigen and staphylococcus toxin. In the last group one rabbit developed a titer of 1: 640 with the homologous antigen and averaged between 1: 80 and 1: 160 at subsequent bleedings. This serum was used for practically all of the tests to be described. Two attempted immunizations by intravenous injections of tumor antigen alone, and two by intravenous injection of tumor antigen plus staphylococcus toxin failed to give rise to specific tumor antibodies. In no normal rabbits have antibodies against 15091 a been demonstrated. Heterophile antibodies were always found after immunization, even in certain instances in which the serum contained no complement-fixing antibodies against 15091 a antigen. As described above, these were absorbed from the inactivated serum by sheep cells before use.
(a) Antiserum which reacted with tumor 15091a in titers of 1: 80 and 1: 160 gave no fixation at all with antigens prepared from the following mouse organs:
Liver-from ABC-ALB strain (repeated tests with 3 preparations of antigen) Liver-from C3H strain (1 test) Liver-from dba strain (2 tests on 1 preparation) Liver-from A-strain (tested 3 No reaction with serum from dba or C3H mice has been found with the anti-15091 a serum. Washed A-strain red blood cells did not absorb 15091a antibodies from the anti-15091a serum.
The reciprocal experiment was attempted. In only 2 out of 5 rabbits were antibodies against A-strain liver induced and these were too feeble (1: 20) for evaluation of results.
(b) In contrast to the above findings is the fixation of complement by the anti-1 5091a rabbit serum in the presence of test antigen prepared from spontaneous mammary carcinorpas from the following strains: C3H-(2 individual tumors, in equal titer to homologous) ABC-ALB-( 1 tumor, in equal titer to homologous) dba-(2 individual tumors; one reacted in titer equal to that of homologous antigen, the other to about half of homologous) C Bagg Albino-(1 tumor in equal titer to homologous)
One antigen from an A-strain carcinoma did not react. One from a C Bagg Albino strain did not react; in this instance, the antigen preparation was probably too dilute, being about 1/10 the average. It should be mentioned that no reactions were obtained with antigens prepared from the livers of the individual mice in which the ABC-ALB and the strongly reacting dba tumor arose.
Tests were made with methylcholanthrene sarcomas; 15091a antiserum reacted with antigen from a sarcoma induced in a dba and in an A-strain mouse in equal titer (1: 80-1: 100) to that with the homologous antigen. Two sarcomas induced in ABC-ALB mice reacted weakly (1: 20) .
Sarcoma 37 antigen did not react with the 15091a antiserum. When the reciprocal experiment was attempted and 2 rabbits were injected with antigens prepared from spontaneous mammary carcinomas that had arisen in C3H and C Bagg Albino mice no antibodies were induced.
(c) Preliminary investigations of the nature of the 15091a antigen were carried out. Antigen prepared from transplants of 15091a carried for 8 generations in C Bagg Albino mice was in no way distinguishable from that prepared from tumor grown in the usual ABC-ALB strain.
The lipoidal nature of the antigen was shown by the following experiment. The opalescent appearance of 15091a antigen diminished somewhat after extraction with 2 portions of ethyl ether ( 1 5 cc. each per 20 cc. of antigen) and the antigen no longer reacted with the antiserum. The ether portions were then evaporated to dryness; the residue was dissolved in 0.5 cc. of cold absolute alcohol and resuspended drop by drop in 1 cc. of normal NaCl until an opalescent suspension resulted. This was used as an antigen and ws found to react to a titer of antiserum of 1: 80 (the original antigen preparation reacted with antiserum diluted 1: 160).
Antigen was prepared from lyophilized 15091a tissue by ether and alcohol extraction (in the above manner); the resulting antigen reacted weakly with the antiserum, 1: 20 to 1: 40, in contrast to 1: 160 of a usual preparation. Extraction of the fresh tumor tissue by absolute alcohol did not yield an antigen which reacted with 15091a antiserum.
No reaction was obtained with the 15091a antiserum and alcoholic or cholesterinized Wassermann antigen, showing that the reactions described above were not merely of non-specific nature.
Conclusions
Earlier histological and growth studies' of regression of transplantable tumor 15091a in mice had suggested that regression followed the acquisition of a resistance against the tumor by the host after implantation.
No circulating complement-fixing antibodies could be demonstrated against the tumor antigen in sera of mice in which the tumor had regressed or had failed to grow after 2 or 3 implants.
Using an aqueous extract of tumor 15091a, antibodies were developed in rabbits which reacted not only with the homologous antigen, but also with antigens from spontaneous mammary carcinomas and methylcholanthrene-induced sarcomas in different strains of mice. The antiserum, however, did not react with the majority of antigens prepared from normal mouse liver, kidney, brain, or mouse sera. This is interpreted as indicating a similarity in antigenic composition between transplantable tumor 15091a and spontaneous and induced malignant tumors, but a difference between it and normal mouse tissue. This result is comparable with that obtained by Dmochowski3 with the Brown-Pearce carcinoma of rabbits and Murray's liposarcoma of guinea-pigs. In spite of the cross reaction between the 15091a antisera and spontaneous and induced mouse tumors, antibodies were not produced when rabbits were injected with preparations from these other tumors. We similarly had difficulty in inducing specific antibodies against normal mouse liver even though the heterophile antibody titer became quite high.
The specifically reacting portion of the 15091a antigen was soluble in ether and alcohol; similar study of the other antigens was prevented by the premature suspension of this investigation because of the war effort. Hoyle reported finding a lipoidal antigen in S-37 which, however, was ether insoluble.4 Many others have found lipoid antigens from tumor tissue (see Hoyle4 for a review of the subject).
Although we were unable to demonstrate complement-fixing antibodies against 15091 a in the sera of mice in which it had regressed, and thus failed to confirm our earlier impression, based on indirect evidence, that regression of transplantable tumor 15091 a followed the acquisition of a specific immunological resistance by the host, we were able to show that this tumor was antigenically different from normal mouse organs, irrespective of strain. It was similar, however, to spontaneous mammary carcinomas and to methylcholanthrene-induced sarcomas, again irrespective of strain of origin. The specifically reacting substance in 15091a antigen was lipoidal in nature, being soluble in ether and absolute alcohol.
Whether the cross reaction of rabbit anti-15091a serum with other malignant tumors is merely a reflection of the high lipoidal content that tumor tissue is known to possess or is something more specific is not yet known. Summary 1. No complement-fixing antibodies for tumor 15091a were demonstrable in sera of mice in which the tumor had failed to grow or had regressed after transplantation.
2. Rabbit anti-15091a serum reacted strongly with heterologous antigen from five spontaneous mammary carcinomas and two methylcholanthrene-induced sarcomas, irrespective of the strain of mice in which they arose; it reacted less strongly with one spontaneous carcinoma and two other induced sarcomas. No reaction was obtained with two other spontaneous mammary carcinomas.
3. Rabbit anti-15091a serum did not react with most of the antigens of various mouse organs tried-liver, kidney, brain, or normal mouse serum; exceptional reactions were obtained once with brain and twice with liver. 4 . The specific antigenic substance in extracts of tumor 15091a was lipoidal, being soluble in ether and alcohol.
5. The results indicate an antigenic dissimilarity between malignant mouse tumor tissue and normal mouse organs.
